Colorectal, MCLA-158-CL01 “MERUS”

Phase 1/2 dose escalation and cohort expansion study evaluating MCLA-158 (petosemtamab) as single agent or in combination in mCRC

Breast, A012301 "LOTAM"

A randomized phase III clinical trial of low-dose Tamoxifen for selected patients with molecular low-risk early-stage breast cancer.

Patient Newsletter 2025 March

Cancer Q&A with HOA: Colorectal Cancer Awareness Month

Profile of Danielle Maciorowski, PharmD - Pharmacy Educator

March 2025 Family Times Educator Profile

1. What inspired you to pursue a career in pharmacy, particularly in hematology and oncology—and what ultimately led you to join Hematology-Oncology Associates of CNY (HOA)?

Pactical Meditation March 13

Practical Meditation

Develop independence in meditation!

Whether you're new to meditation or looking to deepen your practice, this class offers simple, practical techniques you can use immediately. In this session, you'll explore:

Body Awareness, Points of Focus and Your Own Sound as tools to help quiet both the internal and external world.

May 2022

Sun Mon Tue Wed Thu Fri Sat
1
2
3
4
5
6
7
 
 
 
 
 
 
 
8
9
10
11
12
13
14
 
 
 
 
 
 
 
15
16
17
18
19
20
21
 
 
 
 
 
 
 
22
23
24
25
26
27
28
 
 
 
 
 
 
 
29
30
31
1
2
3
4
 
 
 
 
 
 
 

Pages